Verona Pharma PLC - clinical-stage biopharmaceutical company - To cancel trading of shares on AIM market. Last day of trading October 29 and delisting will be effective from October 30. To retain the listing of its American Depositary Shares on the Nasdaq Global Market. As of Thursday last week, 93% of the company's shares are held in ADS form and tradeable on Nasdaq, with 98% of trading in the past six months taking place on Nasdaq.
Current stock price: 61.41 pence
Year-to-date change: down 0.9%
By Tapan Panchal; tapanpanchal@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
